DIAGNOS Announces a Multi-Year Contract with Juarez Health & Medical Tourism Cluster
September 16 2021 - 9:00AM
Diagnos Inc. (“
DIAGNOS” or “the
Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA:
4D4A), a leader in early detection of certain critical health
issues, announces the signing of a 7-year contract with Juarez
Health & Medical Tourism Cluster (“the
Cluster”), headquartered in Ciudad Juarez located
in the State of Chihuahua, Mexico.
The Juarez Health & Medical Tourism Cluster
will be the distributor of DIAGNOS’ CARA platform in Mexico. Its
close ties to the northern region's health care network as well as
in Mexico’s private and public sectors makes it the ideal partner
for DIAGNOS. Mexico has a very high rate of diabetes and
hypertension amongst its population which makes it a prime market
territory for DIAGNOS.
“Patient Safety and quality of medical services
is the lifeblood of our organization. Joining forces with DIAGNOS
aligns perfectly with our permanent goal of making Ciudad Juarez a
Global Health Destination'', said Dr. Lorenzo Soberanes,
President and Board Member of the Juarez Health
and Medical Tourism Cluster. “We plan to allocate DIAGNOS’
turn-key solution in at least 20 sites in the first 2 years of the
contract. The deployment will begin on September 25th and we plan
to distribute DIAGNOS’ technology in 5 points of care (POC) by the
end of 2021”, concluded Dr. Soberanes.
“We look forward to supporting Juarez Health and
Medical Tourism Cluster in its mission by supplying our AI-based
technology and screen their patients in real time, so they can be
monitored and treated by specialists'', noted Mr.
André Larente, President
and CEO DIAGNOS. “DIAGNOS is proud to
have its technology recognized and adopted as a next generation
solution for patient screening at Juarez Health and Medical Tourism
Cluster members. This agreement is an important step in
commercializing the CARA platform in Mexico and Latin America'',
concluded Mr. André Larente.
About Juarez
Health & Medical Tourism ClusterThe Cluster is
a membership-based association that regroups hospitals, clinics,
health providers and hotels focused on providing coordinated
high-quality care services in the context of medical tourism.
Americans have been traveling to Mexico for affordable quality care
services for over 100 years. The Cluster represents the finest
establishments in Juarez. With over 40 affiliated members, the
number of patients treated on a daily basis range between 10 and 12
thousand. The Cluster is the only certified health network in the
country of Mexico and it collaborates with numerous branches of
government throughout the country.
Additional information is available at
https://medicaltourismjuarez.com/
About DIAGNOSDIAGNOS is a
publicly traded Canadian corporation dedicated to early detection
of critical health problems based on its FLAIRE Artificial
Intelligence (AI) platform. FLAIRE allows for quick modifying and
developing of applications such as CARA (Computer Assisted Retina
Analysis). CARA’s image enhancement algorithms provide sharper,
clearer and easier-to-analyze retinal images. CARA is a
cost-effective tool for real-time screening of large volumes of
patients. CARA has been cleared for commercialization by the
following regulators: Health Canada, the FDA (USA), CE (Europe),
COFEPRIS (Mexico) and Saudi FDA (Saudi Arabia).
Additional information is available at
www.diagnos.com and www.sedar.com.
This press release contains forward-looking
information. We cannot guarantee that the forward-looking
information mentioned will prove to be accurate, as there may be a
significant discrepancy between actual results or future events and
those mentioned in this statement. DIAGNOS disclaims any intention
or obligation to publicly update or revise any forward-looking
information, whether as a result of new information, future events
or otherwise. The forward-looking information contained in this
press release is expressly covered by this caution.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
For further information, please contact:
Mr. André Larente, President
DIAGNOS Inc.
Tel: 450-678-8882 ext. 224
alarente@diagnos.ca
Corporate Communications:
Nancy Massicotte
IR Pro Communications Inc.
Dir: +1 604-507-3377
TF: 1-866-503-3377
Email: nancy@irprocommunications.com
Diagnos (TSXV:ADK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Diagnos (TSXV:ADK)
Historical Stock Chart
From Jul 2023 to Jul 2024